Changes in Bcl-2 expression in vaccinia virus-infected human peripheral blood monocytes

Viral Immunology

Volumn 18, Issue 1, 2005, Pages 224-231

  Piróg, Katarzyna A ^a   Kowalczyk, Aleksandra K ^a   Rokita, Hanna B ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; MESSENGER RNA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL ISOLATION; CONTROLLED STUDY; DONOR; GENE EXPRESSION; HEAT SHOCK; HUMAN; HUMAN CELL; KINETICS; MONOCYTE; NONHUMAN; NORMAL HUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RNA ANALYSIS; VACCINIA VIRUS; VIRUS INFECTION;

HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MONOCYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; VACCINIA; VACCINIA VIRUS;

VACCINIA; VACCINIA VIRUS;

EID: 17844373013     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.224     Document Type: Article

References (44)

1. Adams, J.M., and S. Cory. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326.
2. Baixeras, E., A. Cebrian, J.P. Albar, et al. (1998). Vaccinia virus induced apoptosis in immature B lymphocytes: role of cellular Bcl-2. Virus Res. 58:107-113.
3. Brochier, B., F. Costy, and P.P. Pesterer. (1995) Elimination of fox rabies from Belgium using a recombinant vaccinia-rabies vaccine: an update. Vet. Microbiol. 46: 269-279.
4. Broder, C.C., P.E. Kennedy, F. Michaels, et al. (1994). Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 142:167-174.
5. Burleson, F.G., T.M. Chambers, and D.L. Wiedbank (1991). Introduction to quantal virus assays, pp. 53-57. In: F.G. Burleson, T.M. Chambers, D.L. Wiedbrauk, eds. In: Virology: A Laboratory Manual. Academic Press, San Diego.
6. Chomczynski, P., and N. Sacchi (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 62: 156-159.
7. Cooney, E.L., M.J. McElrath, L. Corey, et al. (1993). Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc. N.Y. Acad. Sci. USA 90:1882-1886.
8. Davis, L.G., M.D. Dibner, and J.F. Battey (eds.). (1986). Basic Methods in Molecular Biology. Elsevier Science Publishing, New York.
9. Dignam, J.D. (1990). Preparation of extracts from higher eukaryotes. Methods Enzymol. 182:194-203.
10. Dobbelstein, M., and T. Shenk (1996). Protection against apoptosis by vaccinia virus SPI-2 gene product. J. Virol. 70:6479-6485.
11. Drillen, R., D. Spehner, A.G. Bohbot, et al. (2000). Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 268:471-481.
12. Engelmayer, J., M. Larsson, M. Subklewe, et al. (1999). Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:6762-6768.
13. Garcia, M.A., S. Guerra, J. Gil, et al. (2002). Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene 21:8379-8387.
14. Gross, A., J.M. McDonnell, and S.J. Korsmeyer (1999). Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899-1911.
15. Gubler, U., and B.J. Hoffman (1983). A simple and very efficient method for generating cDNA libraries. Gene 25:263-269.
16. Guzdek, A., K. Stalinska, K. Guzik, et al. (2000). Differential responses of hematopoietic and non-hematopoietic cells to anti-inflammatory cytokines: IL-4, IL-13 and IL-10. J. Physiol. Pharmacol. 51:387-399.
17. Henderson, D.A., and B. Moss (1999). Smallpox and vaccinia. In: S.A. Plotkin and W.A. Orenstein (eds.), Vaccines. Sauders Company, Philadelphia.
18. Humlova, Z., M. Vokurka, M. Esteban, et al. (2002). Vaccinia virus induces apoptosis of infected macrophages. J. Gen. Virol. 83:2821-2832.
19. Hung, J.-J., C.-S. Chung, and W. Chang (2002). Molecular chaperone Hsp90 is important for vaccinia virus growth in cells. J. Virol. 76:1379-1390.
20. Inoue, Y., Y. Sato, M. Nishimura, et al. (1999). Heat-induced drug resistance is associated with increased expression of Bcl-2 in HL60. Anticancer Res. 19:3989-3992.
21. Jaattela, M. (1999). Heat shock proteins as cellular lifeguards. Ann. Med. 31:261-271.
22. Kibler, K.V., T. Shors, K.B. Perkins, et al. (1997). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1992-2003.
23. Kyhse-Andersen, J. (1984). Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylarnide to nitrocellulose. J. Biochem. Biophys. Methods 10:203-209.
24. Laemmli, U.K. (1970). Cleavage of structural proteins. Nature 227:680-685.
25. Lee, S.S., K.J. Cho, S.I. Hong, et al. (1998). Nuclear overexpression of bcl-2 oncoprotein during the progression of human stomach cancer. J. Kor. Med. Sci. 13:153-158.
26. Mackett, M., T. Yilma, J.K. Rose, et al. (1985). Vaccinia virus recombinants: expression of VSV genes and protective immunisation of mice and cattle. Science 227:433-435.
27. McFadden, G., and M. Barry (1998). How poxviruses oppose apoptosis. Semin. Virol. 8:429-442.
28. McLaren, C., H. Cheng, D.L. Spicer, et al. (1976). Lymphocyte and macrophage responses after vaccinia virus infections. Infect. Immun. 14:1014-1021.
29. Moss, B. (1994). Vaccinia virus transcription, pp. 185-205. In: R.C. Conaway and J.W. Conaway, eds. Transcription: Mechanisms and Regulation. Raven Press, New York.
30. Moss, B. (1996). Genetically engineered poxviruses for recombinant gene expression, vaccination and safety. Proc. Natl. Acad. Sci. USA 93:11341-11348.
31. Nahlik K.W., A.K. Mleczko, M.K. Gawlik, et al. (2003). Modulation of GAPDH expression and cellular localization after vaccinia virus infection of human adherent monocytes. Acta Biochim. Pol. 50:667-676.
32. Natuk, R.J., and J.A. Holowczak (1985). Vaccinia virus proteins on the plasma membrane of infected cells. III. Infection of peritoneal macrophages. Virology 147:354-372.
33. Nicotera, P., M. Leist, and E. Ferrando-May (1999). Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. 66:69-73.
34. O'Brien, V. (1998). Viruses and apoptosis. J. Gen. Virol. 79:1833-1845.
35. Ogden, R.C., and D.A. Adams (1987). Electrophoresis in agarose and acrylamide gels. Methods Enzymol. 152: 61-87.
36. Reed, J.C. (1997). Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
37. Savill, J., and V. Fadok (2000). Corpse clearance defines the meaning of cell death. Nature 407:784-788.
38. Shranger, R.L., and G.H. Weiss (1969). Rate zonal centrifugation in a Ficoll gradient. Anal. Biochem. 29: 230-237.
39. Smith, P.K., R.I. Krohn, G.T. Hermanson, et al. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
40. Suzuki, Y.J., M. Mizuno, and L. Packer (1994). Signal trasduction for nuclear factor-κB activation; proposed location of antioxidant-inhibitable step. J. Immunol. 153: 5008-5015.
41. Wasilenko, S.T., A.F. Meyers, K. Van der, et al. (2001). Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating permeability transition pore. J. Virol. 75:11437-11448.
42. Wasilenko, S.T., T.L. Steward, A.F.A. Meyers, et al. (2003). Vaccinia virus encodes a previously uncharacterised mitochondrial-associated inhibitor of apoptosis. Proc. Natl. Acad. Sci. USA 100:14345-14350.
43. Wu, Y., J.W. Mehew, C.A. Heckman, et al. (2001). Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 20:240-251.
44. Yilma, T., D. Hsu, and L. Jones (1988). Protection of cattle against rindpest with infectious vaccinia virus recombinants expressing the HA or F gene. Science 242: 1058-1061.